Overall rank by patents
#25,426
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).
The verdict
Truvian holds 11 US patents across 5 technology areas, rank #25,426 of 50,000 tracked assignees.
Truvian Sciences, Inc. has been granted 11 US utility patents between 2021 and 2025, placing Truvian Sciences, Inc. at rank #25,426 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.9 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Truvian Sciences, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Truvian sits between Trapeze Networks, Inc. (11 patents, rank #25,422) and Ubotic Company Limited (11 patents, rank #25,430) - the closest US assignees by grant volume. The composite Innovation Score of 44.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Truvian Sciences, Inc.'s 12.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Truvian Sciences, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Trapeze Networks, Inc.
11 patents
TricornTech Taiwan
11 patents
Trident Limited
11 patents
TrueVision Systems, Inc.
11 patents
Tsubaki Kabelschlepp GmbH
11 patents
Tyco Electronics (Suzhou) Ltd.
11 patents
U-MHI PLATECH CO., LTD.
11 patents
UBOTIC COMPANY LIMITED
11 patents
Truvian Sciences, Inc.
11 patents
What this shows Truvian holds 11 patents at rank #25,426, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Truvian's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 26% higher than 74% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 9.1% |
| 2022 | 4 | 36.4% |
| 2023 | 1 | 9.1% |
| 2024 | 2 | 18.2% |
| 2025 | 3 | 27.3% |
Top 5 of 5 technology areas
Overall rank by patents
#25,426
Across all tracked assignees
44.2 out of 100
How to use this portfolio
Truvian's 11 grants land it in the top 26% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.